Akoya Biosciences Inc (AKYA) Gross Profit Margin starting from the first quarter 2025 to first quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Akoya Biosciences Inc   (NASDAQ: AKYA)


Akoya Biosciences Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



AKYA Gross Profit Margin (Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
Y / Y Revenue Change -8.68 %
Seq. Revenue Change -29.11 %
Revenue In Millions $15.87
Gross Profit Margin 62.2 %
Gross Profit Margin Total Ranking # 1307
Gross Profit In Millions $9.87
Y / Y Gross Profit Change 17.81 %
Seq. Gross Profit Change -31.4 %


Commenting First Quarter 2025 Gross Profit Margin
Akoya Biosciences Inc experienced contraction in Gross Profit by -31.4 % to $16 millions and Revenue by -29.11 %, while Gross Profit Margin fell to 62.2 %, above company*s average Gross Profit Margin.


Observing first quarter 2025 results within Laboratory Analytical Instruments industry 3 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1307, from total ranking in the previous quarter at 1313.
Learn about Gross Margin
AKYA's Gross Profit Margin first quarter 2025 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 4
Healthcare Sector # 247
Overall # 1294

Gross Profit Margin Statistics
High Average Low
64.27 % 59.83 % 48.21 %
(Dec 31 2024)   (Mar 31 2024)




Other Gross Profit Margin Profitability Ratios
AKYA's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
AKYA's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for AKYA's Competitors
Gross Profit Margin Profit Margin for Akoya Biosciences Inc 's Suppliers
Gross Profit Margin Profit Margin for AKYA's Customers

You may also want to know
AKYA's Annual Growth Rates AKYA's Profitability Ratios AKYA's Asset Turnover Ratio AKYA's Dividend Growth
AKYA's Roe AKYA's Valuation Ratios AKYA's Financial Strength Ratios AKYA's Gross Profit Growth
AKYA's Roa AKYA's Inventory Turnover Ratio AKYA's Growth Rates AKYA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2025, within Laboratory Analytical Instruments Industry Gross Profit MarginMar 31 2025 MRQ Gross ProfitMar 31 2025 MRQ Revenue
Waters Corporation  74.53 %$ 493.146  Millions$ 661.705  Millions
10x Genomics Inc   68.27 %$ 105.445  Millions$ 154.445  Millions
Illumina Inc   65.61 %$ 683.000  Millions$ 1,041.000  Millions
Akoya Biosciences Inc   62.20 %$ 9.871  Millions$ 15.871  Millions
Mettler toledo International Inc   59.51 %$ 525.879  Millions$ 883.744  Millions
Harvard Bioscience Inc   57.52 %$ 12.184  Millions$ 21.184  Millions
Revvity Inc  56.49 %$ 375.546  Millions$ 664.762  Millions
Quanterix Corporation  55.80 %$ 16.415  Millions$ 29.415  Millions
Bio rad Laboratories Inc   52.31 %$ 306.000  Millions$ 585.000  Millions
Agilent Technologies inc   51.92 %$ 866.000  Millions$ 1,668.000  Millions
Seer Inc   50.75 %$ 2.061  Millions$ 4.061  Millions
Cytek Biosciences Inc   48.98 %$ 20.157  Millions$ 41.157  Millions
Bruker Corporation  48.83 %$ 391.200  Millions$ 801.200  Millions
Alamar Biosciences Inc   48.80 %$ 6.389  Millions$ 13.091  Millions
Standard Biotools Inc   48.45 %$ 19.741  Millions$ 40.741  Millions
Bionano Genomics Inc   45.50 %$ 2.938  Millions$ 6.457  Millions
Astrotech Corp  44.38 %$ 0.237  Millions$ 0.534  Millions
Precipio inc   43.42 %$ 2.140  Millions$ 4.929  Millions
Lifeloc Technologies Inc   39.90 %$ 0.909  Millions$ 2.277  Millions
Scientific Industries Inc   36.54 %$ 0.344  Millions$ 0.942  Millions
Avantor Inc   33.82 %$ 534.900  Millions$ 1,581.400  Millions
Kewaunee Scientific Corporation  30.41 %$ 24.038  Millions$ 79.038  Millions
Rapid Micro Biosystems Inc   30.20 %$ 2.176  Millions$ 7.205  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.